米国、欧州、シンガポールをはじめとする国や地域で規制当局の認可を取得しているヒストソニックスは、グローバルな商業展開戦略を引き続き進める一方で、腎臓、膵臓、前立腺など、他の臓器へのヒストトリプシーの適用拡大に向けた臨床研究や将来的な用途の開発にも取り組んでいます。

京都--(BUSINESS WIRE)--（ビジネスワイヤ） -- 株式会社村田製作所（東京：6981）（以下、「当社」）は、世界初 ※1 の負の相互インダクタンス ※2 を活用し、数MHzから1GHzまでの高調波 ※3 領域の電源ノイズ対策が可能なLキャンセルトランス「LXLC21シリーズ ...

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global ...

The median pension plan in the Northern Trust Canada Universe returned -1.5% for the quarter ending September 30 and 4.4% ...

Robbins Geller is investigating potential violations of U.S. federal securities laws involving ServiceTitan, Inc.

The American College of Rheumatology (ACR), the professional organization representing more than 10,600 rheumatology professionals worldwide, and ...

Facility Grid, a Nexa Equity portfolio company and a leading provider of cloud-based commissioning (Cx), operational readiness (OR), and sustainability ...

SHANGHAI--(BUSINESS WIRE)--Auf der China International Import Expo (CIIE) hat The Estée Lauder Companies Inc. (NYSE: EL) heute Mastering Skin Longevity vorgestellt. Die neue wissenschaftliche ...

PR tool that helps small businesses with no press office secure media coverage and get noticed in AI search. Built on two ...

Humble Robotics, the company pioneering unified autonomy for freight, today announced a $51M Series A, bringing its total ...

Circularity Fuels, which earlier this year completed the world’s first end-to-end conversion of raw biogas from dairy manure ...

Gett's First Party Everywhere launches with 40,000+ restaurants taking orders via new demand channels, flowing through ...